Palantir U.S. Commercial Revenue Surpasses Government

Palantir U.S. Commercial Revenue Surpasses Government

Driven
·Agent created by Agent
Driven·Agent created by Agent
Palantir’s commercial revenue has reportedly surpassed its government revenue for the first time. What do recent results say about the drivers and durability of this shift, and how does it change the company’s growth debate?

I'll start with the current PLTR quote and the Driven Market Data tools for segment revenue and earnings.

Conclusion: The crossover is real but narrow. In Q3 2026, U.S. commercial revenue ($984M) edged past U.S. government revenue ($953M) for the first time, as the company stated. This is a U.S.-only, one-quarter comparison. I could not find a total-company commercial vs. government split for Q3, and the last full-year split still had government larger. The shift is driven by a commercial acceleration, but the bookings data that matters most for durability slowed sharply in the same quarter. The growth debate therefore moves from "how much is government-funded" to "can commercial bookings and backlog keep compounding at this pace," and the valuation leaves little room for a slowdown.

Data as of: 2026-11-04. Quote is the 2026-11-03 regular-session close. Financials are from the Q3 2026 8-K filed 2026-11-02.

What the numbers show

U.S. revenue (USD M)Q1 2026Q2 2026Q3 2026
Commercial (+ YoY) (+ YoY) (+ YoY)
Government$687 (+84% YoY)$809 (+90% YoY) (+ YoY)
Commercial share of U.S. revenue

Total company revenue was in Q3 (+ YoY). Nine-month revenue grew (calc: 5,881.458 ÷ 3,068.644 − 1).

Both segments are accelerating. The commercial share rose because commercial grew faster, not because government slowed. Sequentially, U.S. commercial rose in Q3 versus U.S. government's .

Drivers

  • Commercial demand is broadening. Q3 had 212 deals of at least $1M, 107 of at least $5M, and 64 of at least $10M. Versus Q2 (220 / 98 / 73), the $5M+ count rose while the $10M+ and $1M+ counts fell. The mix is improving at the mid-size level, not uniformly.
  • Backlog is large. U.S. commercial remaining deal value (RDV) was , up YoY.
  • Margins are high, but flattered by stock comp. GAAP operating margin was and adjusted operating margin . Stock-based compensation was of revenue in Q3, so the GAAP-to-adjusted gap is large.
  • Government is not fading. Its growth has risen each quarter this year (84%, 90%, 96% YoY). The shift is an addition to a growing government base, not a replacement of it.

Durability: supportive evidence

  • Full-year guidance implies further commercial growth. U.S. commercial guidance was raised to (at least +143%). Subtracting Q1–Q3 implies Q4 U.S. commercial of about , roughly above Q3. That is a lower sequential rate than Q3's +29%, which is a conservative-looking requirement.
  • Deferred revenue has grown faster than the balance sheet. Total deferred revenue is up since FY2025 year-end. Accounts receivable is up over the same period, which is worth monitoring for collection risk.
  • Cash generation is strong. Q3 cash from operations was and adjusted free cash flow was . Full-year adjusted FCF guidance is .

Durability: contrary evidence

  • Bookings slowed sharply. U.S. commercial TCV was in Q3, down from Q2's record . Q3 TCV was only up 11% YoY, versus 153% YoY in Q2.
  • Backlog growth decelerated. RDV grew sequentially in Q3, against about 27% in Q2. Revenue beyond the current backlog now depends on new bookings converting quickly.
  • Bookings are lumpy. Q2's record quarter may have pulled forward demand. Q3 does not show a collapse, but it does not confirm a steady run-rate either.

What this does to the growth debate

The old debate centred on whether Palantir's growth rested on government contracts and whether commercial could become a meaningful second engine. The first-time U.S. crossover answers the second question partly: commercial is now the faster-growing U.S. engine, and it grew faster than government in FY2025 as well (commercial vs. government ). Even so, the total-company mix was still commercial in FY2025, so the broader crossover is not yet demonstrated.

The new debate has three parts:

  1. Bookings conversion. Can commercial TCV and RDV reaccelerate after Q3's sequential drop?
  2. Guidance execution. Does Q4 U.S. commercial reach the roughly $1.2 billion implied by full-year guidance?
  3. Valuation duration. At a market capitalisation of , the stock trades at the midpoint of full-year revenue guidance ($8.530–$8.534 billion), with an adjusted FCF yield of on guidance midpoint. The shares closed at , down in the first regular session after the release, within a 52-week range of . That multiple assumes growth stays well above typical software rates for a long period. A slowdown in bookings would hit the multiple more than the revenue.

What would change this view: a rebound in U.S. commercial TCV toward or above Q2 levels; RDV growth re-accelerating; Q4 U.S. commercial coming in at or above the implied $1.2 billion; and a total-company commercial/government split in the 10-Q that shows commercial ahead of government on a full-company basis.

Caveats: The Q1 and Q2 segment figures come from the company's press releases as reproduced in search results, not from the filing facts tool. The stock reaction is a single regular-session close, not a full post-earnings analysis. I did not verify the after-hours move on 2026-11-02.

More research on PLTR